To the Editor: Two important contributions to the debate on the in-vivo dopamine D2 B m a x determined by positron emission tomography in relation to schizophrenia were recently published. However, although Farde et al. (1987) found no receptor den sity differences between normal and drug-naive schizophrenic subjects, Wong et aI. (1986a) re ported a 2.6-time higher density in drug-naive schizophrenic patients as compared with normals. In addition, the latter group reported considerably lower B levels for the normal brain. The method m a x Wong et aI. applied was based on a mathematical model, published in the present journal (Wong et aI., 1986b; "WEA' , hereafter) . WEA developed a "model-dependent" correction for the appearance of metabolites. However, we think that this correc tion may lead to erroneous results, which may partly explain the contrasting results mentioned be fore. Remark 1. WEA assume that metabolites may pass the blood-brain barrier and that they may bind reversibly to receptors. Define VeereD and Vapp(1) as
where Veer(1) and Vapp(1) are the "kinetic" vol ume of distribution and the apparent "kinetic" vol ume of distribution, respectively, in the cerebellum. Mm(1) is the quantity of labeled metabolites in the cerebellum and Cm (1) (1) , i.e., Mm(1) = O. Thus, in contrast to the assumption stated, metabolites do not occur in the brain after the onset of steady state. In addition, the correction is not allowed for the early period where Eqs. 3 and 4 are not valid.
Remark 2. The partition coefficient X. is estimated from the ordinate intercept of asymptote of the ap parent linear part of the curve of Eq. 19 of WEA (see also Eq. 3). The parameter X. is defined as X. = K,/k2. At steady state, Veer(1) = X.. However, when metabolism and excretion are involved, Veer(1) = Mf(1)/Ca(1) tends to a constant, x.' #-x.. When the sum of the transfer constants of these processes is negligible as compared with k2 then X. == x.'. Now, define Sapp(1) as
From Eq. 2 it follows that
Substituting Eq. 7 in Eq. 1 leads after algebraic rearrangements (using Eq. 6) to the model-function Vapp(1) of Sapp(1):
[8] Assuming that Mm(1) = 0 (see remark 1), Eq. 8 reduces to
The ordinate intercept of the tangent of Eq. 9 at 8app(1) � 0, i.e., Vee/1) = "A' should be equal to "A' if the model-dependent correction of WEA is valid. The ordinate intercept of the tangent of a function, fF(x) , is generally given by: I = f(xi) -x;(df(x)/ dx)x, where Xi denotes a particular point of the ab scis�a. Applying this equation to Eq. 9 in respect to 8app(1) leads, after algebraic rearrangements, to an estimator of Vee r (1) as a function of 8app (1):
120 0 60 120 0 60 120 min TIME of a rather simple metabolic system (Fig. 1) . In all cases I < "A'. In case A, where the rate constants of metabolism and excretion are negligible as com pared with k2' "A' == "A, and I estimates these param eters rather well. However, in case B and more pronounced in case C, where these rate constants are significantly involved, the intercept, I, esti mates "A more or less correctly at some particular values of time, but underestimates both "A' and "A most times. Applying the model-dependent meta bolic correction of WEA to such a system leads to uncertain results in case of significant but unknown rate constants of metabolism (and excretion).
In conclusion, the model-dependent correction leads to a metabolism-dependent biased estimator, I, of "A'. As a result, Ca(1) will be underestimated by Eq. 20, WEA, where "A should be substituted for "A'.
[10]
where Ca'(1) and Cm'(1) are the first derivatives of Ca(1) and Cm(1) with respect to T. The first term of the right side of Eq. 10 �Vee r (1) and the second term >0, for 8app(1) ;;;.: O. Clearly, the intercept, I, underestimates "A' at any time. We investigated the behavior of I versus time by computer simulations Consequently, V(1) but not 8(1) (Eq. 17, WEA) will be overestimated, resulting in a higher, metabolism dependent, apparent receptor density. The level of metabolism should therefore be considered in re spect to the reported differences between schizo phrenic and normal subjects.
